Search results
Jul 16, 2021 · 1. INTRODUCTION. Coronavirus disease 2019 (COVID‐19) was initially known to cause respiratory and gastrointestinal symptoms. However, as the pandemic progressed, many atypical features of this infection have become noticed. 1 A dermatologic event has been identified as a significant atypical extrapulmonary involvement of COVID‐19. 2 Figure Figure1 1 illustrates a summary of the multiorgan ...
- Figure 1
Coronavirus disease 2019 (COVID‐19) caused by severe acute...
- Open in a Separate Window
Coronavirus disease 2019 (COVID‐19) caused by severe acute...
- PMC Free Article
The skin complications in the COVID-19 infection were...
- Figure 1
Cutaneous manifestations of COVID-19 are characteristic signs or symptoms of the Coronavirus disease 2019 that occur in the skin.
7,043,660 [4] (reported) 18.2–33.5 million [6] (estimated) Coronavirus disease 2019 ( COVID-19) is a contagious disease caused by the coronavirus SARS-CoV-2. The first known case was identified in Wuhan, China, in December 2019. [7] The disease quickly spread worldwide, resulting in the ongoing COVID-19 pandemic .
- 6,960,770 (reported), 17.6–31.4 million (estimated)
- SARS-CoV-2
- 2–14 days (typically 5), after infection
- Symptomatic and supportive
Apr 12, 2023 · Viral infections of the upper respiratory tract (including Influenza, RSV, and COVID-19) are associated with increased susceptibility to invasive diseases caused by Streptococcus pyogenes (group A streptococcus), including pneumonia, necrotizing fasciitis, toxic shock syndrome, and bacteremia.
Skin is a mirror to internal disease and can be the presenting sign of COVID-19 disease. Several cutaneous manifestations can indicate severe COVID-19 disease. In the present scenario, physicians should know the various cutaneous manifestations of COVID-19 disease for early diagnosis and proper management of the disease.
- Maitreyee Panda, Siddhartha Dash, Biswanath Behera, Abheek Sil
- 10.4103/ijd.ijd_464_21
- 2021
- May-Jun 2021
Acute bacterial skin and skin-structure infections (ABSSSI) is defined in 2013 by the US Food and Drug Administration as a bacterial cellulitis/erysipelas, major skin abscesses, and wound infections. The Infectious Diseases Society of America (IDSA) in 2014 classifies skin and soft-tissue infection …
